In the latest study to attempt to determine whether cigarette smoking increases or decreases a woman's risk for breast cancer, researchers from Harvard University found that active smoking, particularly before giving birth for the first time, modestly increases the risk for the disease.
In the latest study to attempt to determine whether cigarette smoking increases or decreases a woman's risk for breast cancer, researchers from Harvard University found that active smoking, particularly before giving birth for the first time, modestly increases the risk for the disease. These latest findings come from a prospective cohort study, perhaps the largest to date on the subject, involving more than 111,000 women from the Nurses' Health Study from 1976 to 2006 for the active smoking arm and another 36,000 women from 1982 to 2006 for the passive smoking group.
During more than 3,000,000 person-years of follow-up, 8,772 cases of invasive breast cancer occurred. After adjusting for potential confounders, the hazard ratio for breast cancer was 1.06 (95% Confidence Interval [CI], 1.01-1.10) for ever-smokers compared with never-smokers. Incidence was associated with a higher quantity of current (P for trend=.02) and past smoking (P for trend=.003), younger age at smoking initiation (P for trend=.01), longer duration of smoking (P for trend=.01), and more pack-years of smoking (P for trend=.005).
Premenopausal smoking slightly increased the risk (hazard ratio [HR], 1.11; 95% CI, 1.07-1.15), particularly when smoking began before the woman's first pregnancy (HR, 1.18; 95% CI, 1.10-1.27 for every increase of 20 pack-years).
Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB. Cigarette smoking and the incidence of breast cancer. Arch Intern Med. 2011;171(2):125-133.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More